| pubmed-article:16203796 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C0243041 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C0243044 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C1520166 | lld:lifeskim |
| pubmed-article:16203796 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:16203796 | pubmed:issue | 19 Pt 1 | lld:pubmed |
| pubmed-article:16203796 | pubmed:dateCreated | 2005-10-5 | lld:pubmed |
| pubmed-article:16203796 | pubmed:abstractText | To establish the pharmacokinetic and pharmacodynamic profile of the heat shock protein 90 (HSP90) inhibitor 17-allylamino, 17-demethoxygeldanamycin (17-AAG) in ovarian cancer xenograft models. | lld:pubmed |
| pubmed-article:16203796 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16203796 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16203796 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16203796 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16203796 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:WorkmanPaulP | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:RaynaudFloren... | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:GrimshawRache... | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:JudsonIanI | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:KellandLloydL | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:BanerjiUdaiU | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:WaltonMichael... | lld:pubmed |
| pubmed-article:16203796 | pubmed:author | pubmed-author:ValentiMelani... | lld:pubmed |
| pubmed-article:16203796 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16203796 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16203796 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:16203796 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16203796 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16203796 | pubmed:pagination | 7023-32 | lld:pubmed |
| pubmed-article:16203796 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:meshHeading | pubmed-meshheading:16203796... | lld:pubmed |
| pubmed-article:16203796 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16203796 | pubmed:articleTitle | Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. | lld:pubmed |
| pubmed-article:16203796 | pubmed:affiliation | Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom. | lld:pubmed |
| pubmed-article:16203796 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16203796 | lld:pubmed |
